Can you detox safely while pregnant?
Sometimes yes, with the right medical supervision, and sometimes the honest answer is that you need a hospital rather than a rehab. Stopping alcohol or benzodiazepines on your own while pregnant is the genuinely dangerous option. Jintara does not turn pregnant callers away automatically. Each situation is assessed on its own clinical facts, and you will be told plainly what we can and cannot do.
- Pregnant clients are assessed case by case, never excluded by policy.
- Transfer partnerships with Bangkok Hospital Chiang Mai and RAM Hospital.
- Psychiatrist-led medication planning, within what Thai law permits.
- A straight answer at admissions, including when we are the wrong fit.
Fully Licensed and Hospital Accredited
Pregnancy addiction treatment holds two patients at once.
Pregnancy addiction treatment is medically supervised detox and stabilisation carried out alongside monitoring of fetal wellbeing.
That second patient changes everything about the calculation. The same reasoning that makes medical detox a supervised process rather than a private one applies with more weight when there are two people to keep safe. What is safe for a non-pregnant person in withdrawal is not automatically safe here, and some withdrawal syndromes carry risks to the pregnancy that simply do not exist in other cases.
Continuing to use is not the safe alternative either. Drinking through a pregnancy is associated with fetal alcohol spectrum disorders, a group of lifelong conditions with no cure. Continued opioid use without medical support produces unpredictable withdrawal cycles that stress both mother and baby. Continued benzodiazepine use after dependence has formed only delays a taper that still has to happen at some point, under worse conditions.
So the question is rarely whether to act. It is where, and with whom, and how fast.
Stopping suddenly is more dangerous than most people expect.
Withdrawal risk in pregnancy varies sharply by substance, and the differences decide the whole clinical plan.
Alcohol withdrawal is the one people tend to underestimate. It carries a real risk of seizures, and an uncontrolled seizure is a threat to the pregnancy as well as to the mother. Choosing supervised withdrawal management over a home taper is what changes the risk here. Both the clinical picture and the scoring tools are set out in the StatPearls review of alcohol withdrawal syndrome for anyone who wants the detail. Severity is scored rather than guessed, and medication is given to prevent the seizure rather than to treat it after the fact.
Benzodiazepine withdrawal carries the same seizure risk, and pregnancy does not reduce it. Stopping abruptly after dependence has formed can cause seizures that are sometimes fatal. The taper has to be clinically guided and slow, and where fetal wellbeing calls for it, slower still.
Opioid withdrawal is not lethal in the way the other two can be, but it is not harmless. The World Health Organization sets out how withdrawal should be handled in its guidelines on substance use in pregnancy, and the direction of travel in that guidance is toward stability rather than speed. Repeated cycles of withdrawal and re-use place real physical stress on a pregnancy.
Withdrawal Risk And Approach By Substance
| Substance | Main withdrawal risk | Approach during pregnancy |
|---|---|---|
| Alcohol | Seizures, which threaten mother and pregnancy | Medicated detox with CIWA-Ar scoring, never an unsupervised taper |
| Benzodiazepines | Seizures, sometimes fatal, if stopped abruptly | Gradual clinical taper across two to three months, extended if needed |
| Opioids | Physical stress from repeated withdrawal cycles | Stability first, and guidance favours maintenance over withdrawal |
Alcohol
Main withdrawal risk: Seizures, which threaten mother and pregnancy
Approach during pregnancy: Medicated detox with CIWA-Ar scoring, never an unsupervised taper
Benzodiazepines
Main withdrawal risk: Seizures, sometimes fatal, if stopped abruptly
Approach during pregnancy: Gradual clinical taper across two to three months, extended if needed
Opioids
Main withdrawal risk: Physical stress from repeated withdrawal cycles
Approach during pregnancy: Stability first, and guidance favours maintenance over withdrawal
We assess pregnant clients one at a time.
The question we hear most from pregnant callers is whether we will take them at all.
The answer is that there is no blanket exclusion. Denise O'Leary, Jintara's Clinical Director, has confirmed that pregnancy alone does not rule a person out, and that the decision turns on what is medically appropriate for that individual. Her framing is that it would not be an issue unless it were medically unsafe. What the team weighs is the substance involved, the stage of the pregnancy, the medical history, and the level of monitoring the situation would need.
There is something we should say plainly rather than leave you to work out. Jintara has not treated a pregnant client to date. The assessment process is real and the clinical infrastructure behind it is real, including the hospital partnerships, but we are not going to imply an experience base we do not have. You deserve to know that before you decide.
There is a useful next step if you are pregnant and dependent on alcohol, opioids or benzodiazepines. A conversation with our admissions team is where the specifics of your situation get settled. They will tell you what we can offer, and if we are not the right place, they will tell you that too.
Thai law changes which medications are available.
Medication decisions during pregnancy detox in Thailand are shaped by clinical need and by what is legally available in this country, and the second constraint is the one people researching from abroad rarely anticipate.
For alcohol dependence, withdrawal severity is scored using the Clinical Institute Withdrawal Assessment for Alcohol, Revised (CIWA-Ar), and the psychiatrist makes medication decisions from that scoring alongside direct clinical observation. For benzodiazepine dependence there is no equivalent scoring tool, so assessment and observation guide the taper, which can run to two or three months. Those same drugs and dose rules sit on our medication protocols page alongside the alcohol and opioid detail. Preventing a seizure sets the pace, not the calendar.
Opioids are where the honest answer is harder, and it matters enough to state directly. Buprenorphine, including Suboxone, is illegal to prescribe in Thailand. Methadone is available here and is used at Jintara as a taper during the detox phase only, never as long-term maintenance. Opioid withdrawal severity is scored using the Clinical Opiate Withdrawal Scale (COWS).
That creates a real limit you should weigh. NIDA's guidance is that treatment with methadone or buprenorphine is recommended for pregnant women with opioid use disorder, meaning ongoing maintenance rather than withdrawal, because withdrawal itself carries risk to the pregnancy. Jintara cannot provide that maintenance pathway under Thai law. The distinction between a detox taper and maintenance treatment is drawn in SAMHSA TIP 63, which is the clinical framework behind that recommendation. If you are pregnant and opioid dependent, that is a genuine reason to consider a service that can offer maintenance, and our admissions team will say so rather than book you in.
The threshold for hospital transfer drops during pregnancy.
Jintara moves any client to hospital early when something looks wrong, and during pregnancy that line sits lower still.
Darren Lockie, Jintara's founder, describes the standing policy in plain terms, and it is quoted below. The detail of what triggers hospital transfer is set out on its own page and applies here with a lower trigger point. For a pregnant client the same instinct extends to any sign of premature labour, severe dehydration, cardiac symptoms, or withdrawal that is escalating rather than settling.
The transfer partners are Bangkok Hospital Chiang Mai and RAM Hospital, both established working relationships rather than names on a list. Whether a particular pregnancy would need obstetric input at either hospital, and how that would be coordinated, is one of the things settled at the assessment stage rather than assumed in advance.
The practical version is short. If something is not right, the answer is a fast move to hospital-level care, not a wait and see.
“If a client complains of headaches or internal pain, we will probably go immediately to the hospital. We prefer to err on the safe side.
The conversation before admission matters.
A pregnancy alongside substance dependence needs an honest conversation before anyone commits to anything, and that conversation is doing real clinical work rather than screening you.
When you call about a pregnant client, the admissions team will want to understand which substances are involved and for how long, how far along the pregnancy is, whether prenatal care is already in place, and what else is in the medical history. Where a mental health condition sits alongside the substance use, the dual diagnosis assessment runs in parallel rather than afterwards. None of that is a test to pass. It is the information needed to say something useful rather than something reassuring.
If the level of care here fits, the team will walk you through exactly what admission looks like and what monitoring would be in place. If the situation calls for more obstetric or hospital-based care than a residential setting can give, they will say that instead. Darren puts the general philosophy simply, that Jintara tells people what it specialises in, tells them what it does not do, and refers them to places that might suit them better. A pregnant person asking for help deserves that version rather than a warm non-answer.
Planning for after the birth starts on day one.
For a client who completes detox and treatment before delivering, discharge planning has to account for the postpartum period as its own high-risk stretch.
Hormonal change, broken sleep and the demands of a newborn arrive together, and each of those raises relapse risk on its own. The same pattern described in post-acute withdrawal, where mood and sleep stay unsettled well past the detox phase, carries additional weight when it overlaps with the first months of parenthood. Ongoing therapy, peer support and access to postpartum mental health care are part of the plan rather than optional extras.
If a client were to deliver during a treatment stay, the picture changes substantially. Newborn welfare, the possibility of neonatal withdrawal where opioids were used close to delivery, and the mother's own recovery from birth all become part of the clinical situation, and a newborn needs a hospital or specialist neonatal setting rather than a residential program. What an adjusted stay would look like in that scenario is a case-by-case discussion, and it is one to have before admission rather than during it.
The wider point is that a pregnancy does not end at delivery. Treatment for a pregnant person has to account for what happens after the birth, not only for getting through the detox.
Talk with Our Admissions Team
Your enquiry is confidential and goes only to our admissions team.
Common Questions About Pregnancy And Detox
Not on your own. Alcohol withdrawal carries a seizure risk that threatens both you and the pregnancy, and stopping abruptly without medical supervision is the dangerous option rather than the cautious one.
With monitoring, symptom scoring and medication given to prevent seizures, detox can be carried out far more safely. Whether Jintara is the right setting for your particular situation depends on clinical factors that admissions will go through with you.
No. Abrupt opioid withdrawal places physical stress on a pregnancy, which is why clinical guidance favours medical management over rapid cessation.
The wider guidance goes further than that. NIDA recommends ongoing methadone or buprenorphine maintenance for pregnant people with opioid use disorder rather than withdrawal. Buprenorphine is illegal in Thailand and Jintara uses methadone only as a detox-phase taper, so we cannot offer maintenance. If that is what your situation calls for, we will tell you and point you elsewhere.
It is possible where opioids were used during the pregnancy. A newborn can experience neonatal withdrawal after delivery, and severity depends on the substance, the dose and how close to delivery it was used.
This is managed in a hospital or specialist neonatal setting and sits outside what a residential program provides. If it applies to you, it forms part of the admissions conversation rather than something discovered later.
There is no automatic exclusion. Each case is assessed on its clinical facts, including the substances involved, the stage of pregnancy and the monitoring that would be required.
We have not treated a pregnant client to date, and we would rather say that than imply otherwise. The admissions conversation will be honest about what we can and cannot provide.
Any sign of premature labour means an immediate move to hospital, either Bangkok Hospital Chiang Mai or RAM Hospital, both of which are established transfer partners.
The conservative transfer policy applies to every client. It is applied earlier and more strictly for anyone carrying higher clinical risk, and the high-risk conditions during detox page lists the presentations that qualify. Pregnancy sits in that group.
Yes, though the intensity is calibrated. Therapeutic work during early detox stays supportive rather than deep processing for any client, because the body is still stabilising.
Once physical stabilisation is established, therapy continues alongside the medical phase. For a pregnant client the team would set the pace against the physiological situation rather than a standard schedule.
Which substances are involved and how long they have been used, how far along the pregnancy is, whether prenatal care is already in place, and any medical history that might matter.
There is no correct way to open that call. If you are not sure where to start, just say what is happening and let the questions come from there.
Admissions at Jintara will tell you what we can offer and where another service would suit you better, before anyone books anything.
Jintara Rehab is licensed by the Thai Ministry of Public Health as a rehabilitation centre. The clinical information on this page describes Jintara's general approach to supporting clients during the early recovery period. Medical decisions, including medication protocols, are determined by addiction-specialist psychiatrists through our partner hospital pathway. Individual treatment varies based on clinical assessment. This content is for informational purposes and does not constitute medical advice.